Document Detail


5-aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes.
MedLine Citation:
PMID:  19774649     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Epidemiological data suggests that 5-aminosalicylic acid (5-ASA), a nonsteroidal antiinflammatory drug used in the treatment of inflammatory bowel diseases, prevents colorectal cancer development in these patients, although the mechanisms remain incompletely understood. METHODS AND RESULTS: Here we report that 5-ASA prevents growth of several colorectal cancer cell lines by interfering in the cell cycle, i.e., an S-phase and G2/M phase arrest, dependent on 5-ASA dosage and concentration, together with an increased mitotic index. In addition, prolonged cell cycle arrest by repeated 5-ASA treatment induced apoptosis and caused abnormal spindle organization leading to mitotic catastrophe, another form of cell death. CONCLUSION: These observations illustrate that 5-ASA has chemopreventive and chemotherapeutic properties.
Authors:
Pim J Koelink; Marij A C Mieremet-Ooms; Willem E Corver; Kamila Wolanin; Daniel W Hommes; Cornelis B H W Lamers; Hein W Verspaget
Related Documents :
1757399 - Reduction of proliferative heterogeneity of chef18 chinese hamster cell line during the...
1726529 - Possible role of cell cycle-dependent morphology, geometry, and mechanical properties i...
17141209 - The anaphase-promoting complex is required in both dividing and quiescent cells during ...
2715399 - A quantitative morphological study of the bovine vaginal epithelium during the oestrous...
8390519 - Differential expression and activity of p34cdc2 in cultured aortic adventitial fibrobla...
8366059 - Density fluctuation during the cell cycle in the defective vacuolar morphology mutants ...
21840479 - We contain multitudes: the protean face of retinoblastoma.
12425469 - Effect of organic isothiocyanates on the p-glycoprotein- and mrp1-mediated transport of...
1757399 - Reduction of proliferative heterogeneity of chef18 chinese hamster cell line during the...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Inflammatory bowel diseases     Volume:  16     ISSN:  1536-4844     ISO Abbreviation:  Inflamm. Bowel Dis.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-02-15     Completed Date:  2010-05-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508162     Medline TA:  Inflamm Bowel Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  379-89     Citation Subset:  IM    
Affiliation:
Department of Gastroenterology and Hepatology, and Leiden University Medical Center, Leiden, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
Apoptosis / drug effects*
Caco-2 Cells
Cell Division / drug effects
Colorectal Neoplasms / drug therapy*,  pathology*
Flow Cytometry
G2 Phase / drug effects
HCT116 Cells
HT29 Cells
Humans
Mesalamine / pharmacology*
Microtubule-Associated Proteins / metabolism
Mitosis / drug effects
Mitotic Spindle Apparatus / drug effects,  pathology
PPAR gamma / metabolism
S Phase / drug effects
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/BIRC5 protein, human; 0/Microtubule-Associated Proteins; 0/PPAR gamma; 89-57-6/Mesalamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mapping of inflammatory bowel disease in northern France: Spatial variations and relation to affluen...
Next Document:  Interaction of antithyroid drugs with bovine serum albumin: Electrophoretic and fluorimetric study.